Co-Authors
This is a "connection" page, showing publications co-authored by Nir Paran and Yfat Yahalom-Ronen.
Connection Strength
0.693
-
A single dose of recombinant VSV-?G-spike vaccine provides protection against SARS-CoV-2 challenge. Nat Commun. 2020 12 16; 11(1):6402.
Score: 0.230
-
Sensitive Immunodetection of Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern 501Y.V2 and 501Y.V1. J Infect Dis. 2021 08 16; 224(4):616-619.
Score: 0.060
-
Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics. Cell Rep. 2021 06 29; 35(13):109305.
Score: 0.059
-
SARS-CoV-2 uses a multipronged strategy to impede host protein synthesis. Nature. 2021 06; 594(7862):240-245.
Score: 0.059
-
Glucosylceramide synthase inhibitors prevent replication of SARS-CoV-2 and influenza virus. J Biol Chem. 2021 Jan-Jun; 296:100470.
Score: 0.058
-
Design of SARS-CoV-2 hFc-Conjugated Receptor-Binding Domain mRNA Vaccine Delivered via Lipid Nanoparticles. ACS Nano. 2021 06 22; 15(6):9627-9637.
Score: 0.058
-
Detection and infectivity potential of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) environmental contamination in isolation units and quarantine facilities. Clin Microbiol Infect. 2020 Dec; 26(12):1658-1662.
Score: 0.056
-
The coding capacity of SARS-CoV-2. Nature. 2021 01; 589(7840):125-130.
Score: 0.056
-
A panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopes. Nat Commun. 2020 08 27; 11(1):4303.
Score: 0.056